Korify Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Samsara Therapeutics Inc.Jul 2021
Biopharmaceutical company developing first-in-class therapeutics for rare genetic and neurodegenerative diseases with a focus on autophagy enhancement.
BiotechLewes, US
Jens Eckstein(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.